Is Wanbury Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Wanbury Ltd (WANBURY.NS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Wanbury Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Wanbury Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Wanbury Ltd?

Muslim investors may consider investing in Wanbury Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Wanbury Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Wanbury Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Wanbury Ltd updated?

The Shariah compliance status of Wanbury Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Wanbury Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Wanbury Ltd?

You can check the latest Shariah compliance status of Wanbury Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

WANBURY.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 29, 2025

Report Source: 2026 2nd Quarter Report

Wanbury Ltd. Stock Analysis WANBURY.NS

India Health Care Micro Cap Report: Q2, 2026

Wanbury Ltd. is a pharmaceutical company. The firm is engaged in the business of pharmaceutical and related activities, including research. Its API products include Metformin, Metformin Dc, Tramadol, Sertraline, Diphenhydramine HCL, Diphenhydramine Citrate, Mefenamic Acid, Paroxetine Hemihydrate, Promethazine, Glucosamine, Clopidogrel, Levetiracetam and Carvedilol Phosphate Monohydrate. In formulations, the Company has a presence across various therapeutic categories, such as cough and cold solutions, gynecology, orthopedics, nutraceuticals, gastrointestinal, anti-inflammatory and analgesics. The firm is also focused on the development of products like ketamine, rivaroxaban, montelukast, sitagliptin and a few others to reduce dependency on metformin and sertraline. The firm has facilities in Tanuku, Andra Pradesh, and Patalganga, Maharashtra.

Key Statistics of Wanbury Ltd (WANBURY.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹252.00₹259.00

Today's Open

₹253.60

Volume

22.16K

P/E Ratio (TTM)

28.60

52 Week Range

₹161.50₹329.70

Market Cap

9.01B

Avg. Volume

47.16K

Dividend Yield

Financial Metrics & Statements of Wanbury Ltd (WANBURY.NS)

FAQ's for Wanbury Ltd (WANBURY.NS)

According to Musaffa’s Shariah screening methodology, Wanbury Ltd (WANBURY.NS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.